911±¬ÁÏÍø

Affiliates of NYC-based American Securities LLC, the majority owner of global specialty chemicals manufacturer , Vancouver, Wash., have entered into a definitive agreement to sell Emerald to Lanxess AG (U.S. office in Pittsburgh). Completion of the sale is expected in the second half of 2021, following customary and requisite approval and will include all of Emerald’s operations in Washington state, the United Kingdom, and the Netherlands. These facilities are used to manufacture consumer-friendly preservatives, nature-identical aroma chemicals, low-VOC coalescents, and non-phthalate plasticizers and plastics modifiers.

Formed in 2006 from the divesture of several specialty chemical 911±¬ÁÏÍøes from Lubrizol, Emerald was acquired by affiliates of American Securities in 2014. Since then, Emerald has continued to invest in expanding capabilities and growth, including the acquisition of Innospec Widnes Ltd in the United Kingdom in 2015, a $40 million major expansion at its facility in Rotterdam, and the launch of several new product lines. Additives for plastics include non-phthalate PVC plasticizers and polyolefin modifiers, including antioxidants and nucleating agents.

Featured Content

How Vacuum Drying Is Revolutionizing Plastics Processing READ MORE

AI-Driven Capabilities Advance Efficiency and Quality in Your Molding Environment READ MORE

A Purge Solution for the Blow Molding and Compounding Industries READ MORE

“Emerald has grown at a rapid pace, and we have continuously invested in expanding our capabilities. Lanxess has a sterling reputation within our industry as a global supplier, with a foundation built on exceptional service, responsible manufacturing and growth year-over-year. This is a fantastic development for Emerald, as Lanxess will be able to capitalize on existing successes and position of our 911±¬ÁÏÍøes to continue growing synergistically,” said Edward Gotch, CEO and board member of Emerald.

Said Mathias Zachert, Lanxess AG’s chairman of the board of management, “We are gaining further momentum on our growth course. The 911±¬ÁÏÍøes of Emerald Kalama Chemical are an ideal fit for us. We will further strengthen our Consumer Protection segment and open up new application areas with strong margins, for example in the food industry and animal health sector. In addition, we will also enlarge our presence in our growth region of North America.”

Said Scott Wolff, chairman of Emerald and a managing director of American Securities, “We are proud to have supported Ed and the talented Emerald management team to drive growth and expansion of capabilities during our partnership. This transaction completes our original strategy for Emerald, which was to find strategic homes for each of the company’s distinct 911±¬ÁÏÍøes to help them continue to grow.”